2628 studies found for:    "Blood Coagulation Disorders"
Show Display Options
Rank Status Study
1 Recruiting Accuracy of a Portable International Normalized Ratio Monitor in Elderly Patients
Conditions: Blood Coagulation Disorders;   Blood Coagulation Disorder With Prolonged Bleeding Time;   Blood Coagulation Disorder With Prolonged Coagulation Time
Interventions: Device: INR capillary measurement with INRatio 2 device;   Other: antiphospholipid antibodies and lupus anticoagulant
2 Completed Treatment and Management of Women With Bleeding Disorders
Conditions: Menorrhagia;   Blood Coagulation Disorders;   Blood Platelet Disorders;   Von Willebrand Disease;   Hematologic Disease
Interventions: Drug: Tranexamic Acid;   Drug: Desmopressin Acetate
3 Recruiting Fibrinogen for Treatment of Pediatric Dilutional Coagulopathy. FibPaed Study.
Conditions: Blood Coagulation Disorders;   Hemorrhage
Intervention: Drug: Human fibrinogen concentrate
4 Recruiting Antibiotic-associated Coagulopathy
Conditions: Infection;   Blood Coagulation Disorders
Intervention:
5 Completed The Use of Cyclokapron for Treatment and Management of Women With Bleeding Disorders
Conditions: vonWillebrand Disease;   Hemophilia;   Platelet Coagulation Disorders
Intervention: Drug: Cyclokapron
6 Recruiting Evaluating URMC's Massive Transfusion Protocol
Conditions: Blood Coagulation Disorders;   Trauma;   Acute Coagulopathy
Intervention: Other: Blood collection
7 Completed A Prospective Evaluation of Thromboelastography for Identifying Coagulopathy in Severely Injured Patients
Condition: Coagulopathy
Intervention: Procedure: RapidTEG test
8 Completed Bioequivalence of NovoSeven® and a NovoSeven® Formulation Stable at Room Temperature in Healthy Male Subjects
Conditions: Acquired Bleeding Disorder;   Acquired Haemophilia;   Congenital Bleeding Disorder;   Congenital FVII Deficiency;   Glanzmann's Disease;   Haemophilia A With Inhibitors;   Haemophilia B With Inhibitors;   Healthy
Intervention: Drug: activated recombinant human factor VII
9 Completed Observational Study on the Efficacy and Safety of NovoSeven® During "Real-life" Usage in Germany
Conditions: Congenital Bleeding Disorder;   Congenital FVII Deficiency;   Glanzmann's Disease;   Acquired Bleeding Disorder;   Acquired Haemophilia
Intervention: Drug: activated recombinant human factor VII
10 Completed Study of Safety and Efficacy of Antihemophilic Factor/Von Willebrand Factor Complex in Surgical Subjects With Von Willebrand Disease (vWD)
Conditions: Von Willebrand Disease;   Blood Coagulation Disorders;   Blood Platelet Disorders;   Hematologic Disease
Intervention: Drug: Blood coagulation Factor VIII and vWF, human
11 Completed
Has Results
Efficacy and Safety Study of BERIPLEX® P/N (Kcentra) Compared With Plasma in Patients With Acute Major Bleeding Caused by Anticoagulant Therapy
Conditions: Blood Coagulation Disorders;   Acute Major Bleeding
Interventions: Biological: Beriplex® P/N (Kcentra);   Biological: Fresh frozen plasma
12 Completed
Has Results
An Open-label, Randomized, Multicenter Phase IIIb Study to Assess the Efficacy, Safety and Tolerance of BERIPLEX® P/N (Kcentra) Compared With Plasma for Rapid Reversal of Coagulopathy Induced by Vitamin K Antagonists in Subjects Requiring an Urgent Surgical Procedure
Condition: Reversal of Coagulopathy
Interventions: Biological: Beriplex® P/N (Kcentra);   Biological: Fresh frozen plasma
13 Withdrawn An Observational Study of Early Coagulopathy, or Clotting Disorder, in Injured Patients
Condition: Trauma-induced Coagulopathy
Intervention:
14 Not yet recruiting Pre-hospital Anti-fibrinolytics for Traumatic Coagulopathy and Haemorrhage (The PATCH Study)
Conditions: Wounds and Injuries;   Acute Coagulopathy
Interventions: Drug: Tranexamic Acid;   Drug: Placebo
15 Completed Dilutional Coagulopathy in Patients Undergoing Elective Surgery
Condition: Blood Coagulation Disorder
Intervention: Drug: Fibrinogen
16 Terminated Sequestration of Platelets Prior to Bypass Reduces Bleeding After Cardiac Surgery
Conditions: Cardiac Surgical Procedures;   Cardiopulmonary Bypass;   Blood Platelet Disorders;   Blood Coagulation Disorders
Intervention: Procedure: Platelet rich plasma sequestration
17 Active, not recruiting Effekt-2 - Efficacy and Safety of Long-term Treatment With KOGENATE® FS in Latin America
Conditions: Blood Coagulation Disorders;   Hemophilia A
Intervention: Biological: Recombinant Factor VIII (Kogenate FS, BAY14-2222)
18 Completed
Has Results
Trial to Evaluate the Efficacy and Safety of a New Full Length Recombinant Human FVIII for Hemophilia A
Conditions: Blood Coagulation Disorders;   Hemophilia A
Interventions: Biological: Recombinant Factor VIII (BAY81-8973);   Biological: Recombinant Factor VIII (Kogenate FS, BAY14-2222)
19 Unknown  Kid Cards: Teaching Kids About Medicines
Conditions: Hemophilia;   Sickle Cell Disease;   Neoplasms;   Blood Coagulation Disorders
Intervention: Behavioral: Medication Education for Children
20 Completed Evaluation of the Reasons and Consequences of Bleeding in Late Teens and Early Adulthood Patients With Severe Hemophilia A
Conditions: Hematologic Disease;   Blood Coagulation Disorders
Intervention: Behavioral: Recombinant Factor VIII (Kogenate, BAY 14-2222)

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years